Perpetual Ltd Increases Stock Position in Centene Corporation $CNC

Perpetual Ltd increased its position in shares of Centene Corporation (NYSE:CNCFree Report) by 36.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 67,228 shares of the company’s stock after purchasing an additional 18,095 shares during the quarter. Perpetual Ltd’s holdings in Centene were worth $2,766,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Baird Financial Group Inc. purchased a new stake in shares of Centene during the first quarter valued at approximately $236,000. Sivia Capital Partners LLC boosted its position in Centene by 80.0% in the second quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after purchasing an additional 4,315 shares during the last quarter. Schroder Investment Management Group grew its stake in Centene by 5.0% in the 2nd quarter. Schroder Investment Management Group now owns 76,002 shares of the company’s stock valued at $4,125,000 after purchasing an additional 3,600 shares during the period. Lido Advisors LLC increased its position in shares of Centene by 33.6% during the 2nd quarter. Lido Advisors LLC now owns 6,912 shares of the company’s stock valued at $375,000 after purchasing an additional 1,739 shares during the last quarter. Finally, CW Advisors LLC increased its position in shares of Centene by 20.3% during the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock valued at $264,000 after purchasing an additional 820 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Stock Performance

NYSE CNC opened at $35.09 on Friday. The company’s 50 day moving average is $39.20 and its 200-day moving average is $38.76. The firm has a market cap of $17.26 billion, a P/E ratio of -2.58, a price-to-earnings-growth ratio of 0.78 and a beta of 0.59. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s revenue was up 21.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Sell-side analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on CNC. Robert W. Baird increased their price target on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. JPMorgan Chase & Co. reduced their target price on shares of Centene from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Thursday, March 19th. Jefferies Financial Group lowered their price target on shares of Centene from $43.00 to $37.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Sanford C. Bernstein reissued an “outperform” rating and set a $59.00 price objective on shares of Centene in a report on Tuesday, January 6th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research report on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Centene currently has an average rating of “Hold” and a consensus price target of $41.81.

Read Our Latest Research Report on CNC

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.